Key result
Applying a Bayesian sceptical prior combined with a random effects meta-analysis would have suitably tempered early enthusiasm for intravenous magnesium following myocardial infarction.
Why the study?
Does intravenous magnesium provide benefits following myocardial infarction, and how do Bayesian meta-analysis methods affect the interpretation of conflicting trial results?
Meta-Analysis
Does intravenous magnesium provide benefits following myocardial infarction, and how do Bayesian meta-analysis methods affect the interpretation of conflicting trial results?
This methodological study demonstrates that applying a Bayesian framework with a sceptical prior and random effects model to meta-analyses can prevent premature enthusiasm for treatments like intravenous magnesium in myocardial infarction when early trials conflict with subsequent mega-trials.
Sceptical Bayesian priors may avert misguided adoption of ineffective post-MI therapies; challenges conventional meta-analysis methods in cardiovascular research.
BACKGROUND: There has been extensive discussion of the apparent conflict between meta-analyses and a mega-trial investigating the benefits of intravenous magnesium following myocardial infarction, in which the early trial results have been said to be 'too good to be true'. METHODS: We apply Bayesian methods of meta-analysis to the trials available before and after the publication of the ISIS-4 results. We show how scepticism can be formally incorporated into an analysis as a Bayesian prior distribution, and how Bayesian meta-analysis models allow appropriate exploration of hypotheses that the treatment effect depends on the size of the trial or the risk in the control group. RESULTS: Adoption of a sceptical prior would have led early enthusiasm for magnesium to be suitably tempered, but only if combined with a random effects meta-analysis, rather than the fixed effect analysis that was actually conducted. CONCLUSIONS: We argue that neither a fixed effect nor a random effects analysis is appropriate when the mega-trial is included. The Bayesian framework provides many possibilities for flexible exploration of clinical hypotheses, but there can be considerable sensitivity to apparently innocuous assumptions.
No takes yet. Share an insight, caveat, or question.
Higgins et al. (2002) conducted a meta-analysis in myocardial infarction. intravenous magnesium was evaluated. Applying a Bayesian sceptical prior combined with a random effects meta-analysis would have suitably tempered early enthusiasm for intravenous magnesium following myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: